Post-transfusion Platelet Count
NCT02601131 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2016-11-29
Summary
The purpose of this study is to identify how the platelet count, complement system and endothelial markers are affected over time, after platelet transfusion in 4 different hematological patient groups.
Conditions
Interventions
- BIOLOGICAL
-
Platelet transfusion
Sponsors & Collaborators
-
Region Skane
lead OTHER
Principal Investigators
-
Thomas Kander, MD, PhD · Region Skåne
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
Countries
- Sweden
Study Locations
More Related Trials
-
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
NCT02065882 ·Status: COMPLETED ·Phase: PHASE3
-
Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia
NCT02032134 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion
NCT01955811 ·Status: COMPLETED ·Phase: PHASE4
-
Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With Thrombocytopenia
NCT01928017 ·Status: COMPLETED
-
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220 ·Status: UNKNOWN
-
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
NCT00151866 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
NCT04278924 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days
NCT00261924 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
NCT00903929 ·Status: COMPLETED ·Phase: PHASE1
-
Role of ROTEM and Platelet Indices in Thrombocytopenic Patients .
NCT05850481 ·Status: UNKNOWN
-
Pediatric Disease Registry in Essential Thrombocythaemia (ET)
NCT01198717 ·Status: COMPLETED
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Association of Platelet Parameters With Bleeding Severity in Children With ITP
NCT03810352 ·Status: COMPLETED
-
Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
NCT02298933 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet Volunteers, Longitudinal and Multi-omic Study
NCT07137429 ·Status: RECRUITING
-
Comparison Between Centrifugation Based and Membrane Based Plasma Exchange
NCT06652516 ·Status: COMPLETED ·Phase: NA
-
TPE in Rennes Hospital
NCT03888417 ·Status: COMPLETED
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
Study of Immune Thrombocytopenia Pathogenesis:
NCT02042560 ·Status: COMPLETED
-
Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)
NCT06282432 ·Status: ACTIVE_NOT_RECRUITING
-
Bleeding Prediction in Thrombocytopenia
NCT02306044 ·Status: COMPLETED
-
Clinical Study of Combined Platelet Transfusion
NCT06613425 ·Status: RECRUITING ·Phase: PHASE4
-
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
NCT01152229 ·Status: COMPLETED
-
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)
NCT03469661 ·Status: COMPLETED
-
Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada
NCT03784898 ·Status: COMPLETED ·Phase: PHASE4